Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,587,955 papers from all fields of science
Search
Sign In
Create Free Account
pyrextramine
Known as:
N,N''-(dithio-2,1-ethanediyl)bis(N'-(pyrrol-2-ylmethyl)-1,6-hexanediamine)
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Broader (1)
Cystamine
analogs & derivatives
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Alpha-1 and alpha-2 adrenoceptor binding in cerebral cortex: Competition studies with [3H]prazosin and [3H]idazoxan
T. A. R. F.R.S.Q.
,
R. Briére
,
L. Grondin
Journal of neural transmission
2005
Corpus ID: 29880762
The tritiated adrenergic antagonists prazosin ([3H]PRZ) and idazoxan ([3H]IDA, or RX-781094) bind specifically and with high…
Expand
1985
1985
Structure-activity relationships among benextramine-related tetraamine disulfides at peripheral alpha-adrenoreceptors.
P. Angeli
,
L. Brasili
,
E. Brancia
,
D. Giardiná
,
W. Quaglia
,
C. Melchiorre
Journal of Medicinal Chemistry
1985
Corpus ID: 21188324
Several N,N''-(dithiodi-2,1-ethanediyl)bis[N'-(arylmethyl)-1,6-hex anediamines] were prepared and evaluated for their blocking…
Expand
1985
1985
THE PREJUNCTIONAL α2‐ADRENOCEPTOR ANTAGONIST ACTIVITY OF PYREXTRAMINE
B. Dave
,
D. Mottram
1985
Corpus ID: 71572595
Alpha-adrenoceptors have a widespread distribution and are involved in the mode of action of many clinically important groups of…
Expand
1984
1984
N,N''-(dithio-2,1-ethanediyl)bis[N'-(pyrrol-2-ylmethyl)-1, 6,- hexanediamine] (pyrextramine), a new irreversible alpha 1-adrenoreceptor blocking agent of the tetramine disulfide class.
L. Brasili
,
P. Angeli
,
E. Brancia
,
C. Melchiorre
European Journal of Pharmacology
1984
Corpus ID: 4553742
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE